Hi Ice your question ( How does the company lift its MC to the billion or beyond ) Answer , Data just pure Data that far exceeds the oppositions products and so far so good . When it comes to one’s health no one is going to utilise a vastly inferior TAVR probably not even the doctors . Time will tell here and the further AVR can drive this into the trials the better the outcome will be for investors . From a mechanical point of view it’s not hard to see the advantages of AVRs valve . The stitches in the current valves make them a larger diameter to install . I am assuming the larger valves make the chances of dislodging calcification out of arteries much greater when the TAVR is installed . My own Dr has had 2 patients over the last few yrs who had strokes while getting TAVRs installed . That’s just one issue and current data shows performance wise the AVRs valve far exceeds every other by a long way . Hold tightly it’s going to be a exciting year next year for AVR IMO .. GLTATH
AVR Price at posting:
$22.91 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)